日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

US Food and Drug Administration Approval Summary: Imetelstat for Selected Patients With Low- to Intermediate-1 Risk Myelodysplastic Syndromes With Transfusion-Dependent Anemia

美国食品药品监督管理局批准摘要:伊美替司他用于治疗部分低危至中危-1型骨髓增生异常综合征伴输血依赖性贫血患者

Kim, Nina; Pulte, E Dianne; Ehrlich, Lori A; Ionan, Alexei C; Haupert, Spencer; Vallejo, Jonathon; Green, Francis; Zheng, Nan; Wang, Yun; Liu, Jiang; Blanco, Javier G; Dorff, Sarah E; Booth, Brian; Choe, Moran; Gehrke, Brenda; Bhatnagar, Vishal; Theoret, Marc; Pazdur, Richard; De Claro, R Angelo; Norsworthy, Kelly J

FDA Approval Summary: Ivosidenib for Treatment of Adult Patients with Relapsed/Refractory Myelodysplastic Syndrome with an IDH1 Mutation

FDA批准摘要:Ivosidenib用于治疗伴有IDH1突变的复发/难治性骨髓增生异常综合征成人患者

Woods, Ashley C; Pulte, E Dianne; Wang, Xin; Vallejo, Jonathon; Chadda, Ritu; Zheng, Nan; Blanco, Javier G; Dorff, Sarah E; Li, Hongshan; Liu, Jiang; Okusanya, Olanrewaju O; Pazdur, Richard; Theoret, Marc R; de Claro, R Angelo; Norsworthy, Kelly J

Treatment of Acute Myeloid Leukemia in the Community Setting

社区环境下急性髓系白血病的治疗

Al-Juhaishi, Taha; Dela Cruz, Servillano; Gupta, Rohan; Keiffer, Gina; Morrison, Vicki A; Shapira, Iuliana; Woods, Ashley; Norsworthy, Kelly; de Claro, Romeo Angelo; Theoret, Marc R; Garg, Ravin; Pulte, Elizabeth Dianne

Isla: integrating full-scale ISA semantics and axiomatic concurrency models (extended version)

Isla:集成全规模 ISA 语义和公理化并发模型(扩展版)

Armstrong, Alasdair; Campbell, Brian; Simner, Ben; Pulte, Christopher; Sewell, Peter

The underestimated impact of excess body weight on colorectal cancer risk: Evidence from the UK Biobank cohort

超重对结直肠癌风险的影响被低估:来自英国生物银行队列的证据

Safizadeh, Fatemeh; Mandic, Marko; Pulte, Dianne; Niedermaier, Tobias; Hoffmeister, Michael; Brenner, Hermann

Improvement in Quality-of-Life-Related Outcomes Following Treatment with IncobotulinumtoxinA in Adults with Limb Spasticity: A Pooled Analysis

使用A型肉毒杆菌毒素治疗成人肢体痉挛后,生活质量相关结局得到改善:一项汇总分析

Molteni, Franco; Wissel, Jörg; Fheodoroff, Klemens; Munin, Michael C; Patel, Atul T; Althaus, Michael; Comes, Georg; Dekundy, Andrzej; Pulte, Irena; Scheschonka, Astrid; Vacchelli, Matteo; Santamato, Andrea

Response Rate, Event-Free Survival, and Overall Survival in Newly Diagnosed Acute Myeloid Leukemia: US Food and Drug Administration Trial-Level and Patient-Level Analyses

新诊断急性髓系白血病患者的缓解率、无事件生存期和总生存期:美国食品药品监督管理局试验层面和患者层面的分析

Norsworthy, Kelly J; Gao, Xin; Ko, Chia-Wen; Pulte, E Dianne; Zhou, Jiaxi; Gong, Yutao; Shen, Yuan Li; Vallejo, Jonathon; Gwise, Thomas E; Sridhara, Rajeshwari; Deisseroth, Albert B; Farrell, Ann T; de Claro, R Angelo; Blumenthal, Gideon M; Pazdur, Richard

FDA Approval Summary: Revised Indication and Dosing Regimen for Ponatinib Based on the Results of the OPTIC Trial

FDA批准摘要:根据OPTIC试验结果修订Ponatinib的适应症和给药方案

Pulte, E Dianne; Chen, Haiyan; Price, Lauren S L; Gudi, Ramadevi; Li, Hongshan; Okusanya, Olanrewaju O; Ma, Lian; Rodriguez, Lisa; Vallejo, Jonathon; Norsworthy, Kelly J; de Claro, R Angelo; Theoret, Marc R; Pazdur, Richard

Safety and efficacy of repeat long-term incobotulinumtoxinA treatment for lower limb or combined upper/lower limb spasticity in children with cerebral palsy

重复长期注射A型肉毒杆菌毒素治疗脑瘫儿童下肢或上下肢联合痉挛的安全性和有效性

Kaňovský, Petr; Heinen, Florian; Schroeder, A Sebastian; Chambers, Henry G; Dabrowski, Edward; Geister, Thorin L; Hanschmann, Angelika; Martinez-Torres, Francisco J; Pulte, Irena; Banach, Marta; Gaebler-Spira, Deborah

FDA Approval Summary: Gilteritinib for Relapsed or Refractory Acute Myeloid Leukemia with a FLT3 Mutation

FDA批准摘要:吉瑞替尼用于治疗FLT3突变复发或难治性急性髓系白血病

Pulte, E Dianne; Norsworthy, Kelly J; Wang, Yaping; Xu, Qing; Qosa, Hisham; Gudi, Ramadevi; Przepiorka, Donna; Fu, Wentao; Okusanya, Olanrewaju O; Goldberg, Kirsten B; De Claro, R Angelo; Farrell, Ann T; Pazdur, Richard